Article Text

Download PDFPDF

Original research
Familial bilateral cryptorchidism is caused by recessive variants in RXFP2
  1. Katie Ayers1,2,
  2. Rakesh Kumar3,
  3. Gorjana Robevska2,
  4. Shoni Bruell4,5,
  5. Katrina Bell2,
  6. Muneer A Malik6,
  7. Ross A Bathgate4,5,
  8. Andrew Sinclair1,2
  1. 1 Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
  2. 2 Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia
  3. 3 Paediatric Endocrinology and Diabetes Unit, Department of Paediatric Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  4. 4 Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne, Victoria, Australia
  5. 5 Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia
  6. 6 Department of Paediatric Surgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
  1. Correspondence to Dr Katie Ayers, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia; katie.ayers{at}mcri.edu.au; Professor Rakesh Kumar, Department of Paediatric Surgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; drrakesh.pgi{at}gmail.com

Abstract

Background Cryptorchidism or failure of testicular descent is the most common genitourinary birth defect in males. While both the insulin-like peptide 3 (INSL3) and its receptor, relaxin family peptide receptor 2 (RXFP2), have been demonstrated to control testicular descent in mice, their link to human cryptorchidism is weak, with no clear cause–effect demonstrated.

Objective To identify the genetic cause of a case of familial cryptorchidism.

Methods We recruited a family in which four boys had isolated bilateral cryptorchidism. A fourth-degree consanguineous union in the family was reported. Whole exome sequencing was carried out for the four affected boys and their parents, and variants that segregated with the disorder and had a link to testis development/descent were analysed. Functional analysis of a RXFP2 variant in cell culture included receptor localisation, ligand binding and cyclic AMP (cAMP) pathway activation.

Results Genomic analysis revealed a homozygous missense variant in the RXFP2 gene (c.1496G>A .p.Gly499Glu) in all four affected boys and heterozygous in both parents. No other variant with a link to testis biology was found. The RXFP2 variant is rare in genomic databases and predicted to be damaging. It has not been previously reported. Functional analysis demonstrated that the variant protein had poor cell surface expression and failed to bind INSL3 or respond to the ligand with cAMP signalling.

Conclusion This is the first reported genomic analysis of a family with multiple individuals affected with cryptorchidism. It demonstrates that recessive variants in the RXFP2 gene underlie familial cryptorchidism and solidifies the link between this gene and testicular descent in humans.

  • cryptorchidism
  • undescended testis
  • RXFP2
  • exome sequencing
  • familial

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • KA and RK contributed equally.

  • Contributors KA carried out genomic analysis and coordinated the study. RK was the treating clinician and compiled all clinical notes. GR handled DNA and carried out genomic analysis. KB carried out bioinformatic analysis. SB carried out variant functional testing under supervision of RAB. MAM was the treating surgeon and contributed to clinical notes. AS oversaw the study. KA, RK, GR and RAB co-wrote the manuscript.

  • Funding Genomics work and GR are supported by National Health and Medical Research Council of Australia (NHMRC) program grant [1074258]. KLA is supported by an NHMRC project grant [1156942]. AHS is supported by a NHMRC fellowship [1154187]. Research at the Florey was supported by NHMRC project grants [1100676] and [1043750] and the Victorian Government Operational Infrastructure Support Program. RADB is supported by an NHMRC Research Fellowship [1135837].

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data are available upon reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.